Nirvana Life Sciences Inc.
NIRV
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -80.00% | 42.86% | -39.13% | -66.67% | -78.10% |
| Total Receivables | -0.73% | 0.74% | -1.45% | -22.47% | 2.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 3.03% | -6.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.83% | 4.67% | -59.02% | -17.75% | -36.43% |
|
|
|||||
| Total Current Assets | -10.83% | 4.67% | -59.02% | -17.75% | -36.43% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 794.90% | 4.67% | -90.52% | 255.73% | -36.43% |
|
|
|||||
| Total Accounts Payable | -18.42% | 2.20% | 9.39% | 18.16% | -6.00% |
| Total Accrued Expenses | 3.85% | 4.26% | 9.51% | 17.15% | 2.24% |
| Short-term Debt | 104.12% | 17.96% | 16.38% | 13.46% | 155.74% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -3.85% | 4.00% | -3.85% |
| Total Other Current Liabilities | 0.00% | 0.00% | -3.85% | 4.00% | -3.85% |
| Total Current Liabilities | 3.19% | 4.24% | 9.59% | 17.09% | 2.24% |
|
|
|||||
| Total Current Liabilities | 3.19% | 4.24% | 9.59% | 17.09% | 2.24% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 104.12% | 17.96% | 16.38% | 13.46% | 155.74% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8,233.33% | -- | -- | -- | -- |
| Total Liabilities | 17.22% | 4.41% | 9.59% | 17.09% | 2.24% |
|
|
|||||
| Common Stock & APIC | -0.87% | -0.50% | -2.66% | 3.81% | -5.29% |
| Retained Earnings | 0.17% | -0.15% | -1.44% | -3.74% | 3.32% |
| Treasury Stock & Other | 1.60% | -0.49% | 2.42% | 9.62% | 10.31% |
| Total Common Equity | -3.07% | -4.44% | -35.69% | 0.30% | -6.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.07% | -4.44% | -35.69% | 0.30% | -6.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -5.41% | -2.78% | -2.86% | -12.90% | -3.33% |
| Total Equity | -3.08% | -4.42% | -35.52% | 0.23% | -6.97% |
|
|
|||||
